New hope for Hard-to-Treat cancers? early trial of THE-0504 begins
Disease control
Recruiting now
This early-stage trial tests the safety and best dose of a new drug called THE-0504 in 30 adults with advanced solid tumors, including lung, colon, stomach, breast, and pancreatic cancers. The main goal is to find the highest safe dose and check for side effects. Participants mus…
Phase: PHASE1 • Sponsor: Thena Biotech S.r.l. • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC